DK0666929T3 - Fremgangsmåde til inhibering af hyperproliferative cellers replikation - Google Patents

Fremgangsmåde til inhibering af hyperproliferative cellers replikation

Info

Publication number
DK0666929T3
DK0666929T3 DK93924312T DK93924312T DK0666929T3 DK 0666929 T3 DK0666929 T3 DK 0666929T3 DK 93924312 T DK93924312 T DK 93924312T DK 93924312 T DK93924312 T DK 93924312T DK 0666929 T3 DK0666929 T3 DK 0666929T3
Authority
DK
Denmark
Prior art keywords
hyperproliferative cells
hyperproliferative
polypeptide
relates
replication
Prior art date
Application number
DK93924312T
Other languages
Danish (da)
English (en)
Inventor
Steven M Frisch
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of DK0666929T3 publication Critical patent/DK0666929T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK93924312T 1992-10-13 1993-10-13 Fremgangsmåde til inhibering af hyperproliferative cellers replikation DK0666929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/960,112 US5516631A (en) 1992-10-13 1992-10-13 Method of inhibiting replication of hyperproliferative cells
PCT/US1993/009774 WO1994009160A1 (en) 1992-10-13 1993-10-13 Method of inhibiting replication of hyperproliferative cells

Publications (1)

Publication Number Publication Date
DK0666929T3 true DK0666929T3 (da) 2003-09-15

Family

ID=25502805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93924312T DK0666929T3 (da) 1992-10-13 1993-10-13 Fremgangsmåde til inhibering af hyperproliferative cellers replikation

Country Status (10)

Country Link
US (2) US5516631A (de)
EP (1) EP0666929B1 (de)
JP (1) JP3492364B2 (de)
AT (1) ATE240404T1 (de)
CA (1) CA2147127A1 (de)
DE (1) DE69332978T2 (de)
DK (1) DK0666929T3 (de)
ES (1) ES2194849T3 (de)
PT (1) PT666929E (de)
WO (1) WO1994009160A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5776743A (en) 1994-09-06 1998-07-07 La Jolla Cancer Research Foundation Method of sensitizing tumor cells with adenovirus E1A
US6326356B1 (en) 1996-10-18 2001-12-04 Board Of Regents, The University Of Texas System Suppression of neu overexpression using a mini-E1A gene
US5869040A (en) * 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
US5763415A (en) 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
WO1997005898A1 (en) * 1995-08-03 1997-02-20 The Johns Hopkins University School Of Medicine Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
WO1999037753A1 (en) 1998-01-23 1999-07-29 Newbiotics, Inc. Enzyme catalyzed therapeutic agents
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6683061B1 (en) * 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
CA2378187C (en) 1999-07-22 2011-09-13 Newbiotics, Inc. Methods for treating therapy-resistant tumors
US20040266834A1 (en) * 1999-10-14 2004-12-30 Copland John A. Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
US20040191761A1 (en) * 2003-03-27 2004-09-30 Routes John M. Modified adenoviral E1A constructs and methods of use thereof
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
US8895509B2 (en) 2010-11-23 2014-11-25 Georgia Tech Research Corporation MIR-200 family induces mesenchymal-to-epithelial transition (MET) in ovarian cancer cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0560932B1 (de) * 1990-12-04 1996-09-04 The Board Of Regents, The University Of Texas System Methoden und zusammensetzungen zur unterdrückung der zelltransformation durch neu
US5641484A (en) * 1990-12-04 1997-06-24 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
EP0931830B1 (de) * 1993-02-16 2001-03-07 Onyx Pharmaceuticals, Inc. Cytopatische Viren zur Therapie und Prophylaxe der Neoplasie

Also Published As

Publication number Publication date
JP3492364B2 (ja) 2004-02-03
CA2147127A1 (en) 1994-04-28
WO1994009160A1 (en) 1994-04-28
PT666929E (pt) 2003-08-29
US5516631A (en) 1996-05-14
EP0666929A1 (de) 1995-08-16
DE69332978D1 (de) 2003-06-18
JPH08504573A (ja) 1996-05-21
US5866550A (en) 1999-02-02
DE69332978T2 (de) 2004-02-26
EP0666929A4 (de) 1996-07-10
ATE240404T1 (de) 2003-05-15
EP0666929B1 (de) 2003-05-14
ES2194849T3 (es) 2003-12-01

Similar Documents

Publication Publication Date Title
DK0666929T3 (da) Fremgangsmåde til inhibering af hyperproliferative cellers replikation
IE820069L (en) Recombinant dna encoding a polypeptide
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ES8600783A1 (es) Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
ES8700868A1 (es) Metodo de aislamiento de un fragmento de gen que codifica por lo menos una porcion de una proteina.
HUP9900050A1 (hu) Rekombináns adenovírusok, és felhasználásuk adeno-asszociált vírusok (AAV) előállítására, komplementáló sejtvonalak, és az illető adenovírusokat tartalmazó gyógyszerkészítmények
ATE198621T1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
DK240088D0 (da) Fremgangsmaade til transformation af et plantecellematerale
ES544868A0 (es) Procedimiento de obtencion de una proteina de factor estimu-lante de colonias (csf) en primates
DK62881A (da) Rekombinant-dna indeholdende et analysekodningsgen, genetisk konstruerede mikroorganismer med evne til massiv produktion af amylolytiske enzymer og fremgangsmaade til fremstilling af saadanne enzymer
DK0941349T3 (da) Fremgangsmåde til fremstilling af polypeptider i surfactinmutanter af Bacillusceller
EP0182448A3 (de) Verfahren zur Herstellung von Faktor VIII und verwandte Produkte
DK432987D0 (da) Fremgangsmaade til forbedring af ekspressionen af eukaryotprotein
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
DK358787A (da) Vaekstfaktor, nucleotidsekvens kodende for vaekstfaktoren ekspressionsplasmid omfattende nucleotidsekvensen,vaert indeholdende plasmidet protein fremstillet af vaerten, fremgangsmaade til fremstilling af vaekstfaktoren og farmaceutisk praeparat indeholdendevaekstfaktoren
KR890005264A (ko) 인터류킨-2를 생산하는 재조합 진핵 세포, 그의 제조 방법 및 그의 제조용 벡터 및 인터류킨-2의 제조방법
DK619284A (da) Udtrykkelsesplasmid til forbedret produktion af heterologt protein ibakterier og fremgangsmaade til fremstilling af dette protein samtfremgangsmaade til fremstilling af plasmidet
IL129139A0 (en) Vertebrate smoothened proteins
DK0658626T3 (da) Fremgangsmåder til produktion af protein C
PT1007647E (pt) Expressao de ingap em niveis elevados
EP0163243A3 (de) Menschliche T- oder B-Zellinien und Verfahren zur Herstellung von immunologisch aktiven Stoffen mittels derselben
SE8901715L (sv) En plasmid dna-konstruktion innehaallande dna-sekvenser
KR850001803A (ko) 펩티드(peptide)의 제조방법